{"url":"https://nivawealth.com/firms/farallon-capital-management-107322","iapdUrl":"https://adviserinfo.sec.gov/firm/summary/107322","regulatoryAum":52076899000,"crd":"107322","secFileNumber":"801-51763","legalName":"Farallon Capital Management, L.L.C.","displayName":"Farallon Capital Management","website":"http://www.faralloncapital.com","linkedinUrl":"https://www.linkedin.com/company/farallon-capital-management","founded":null,"organization":"Delaware limited liability company","fiscalYearEnd":"December","headquarters":{"street":"One Maritime Plaza, Suite 2100","city":"San Francisco","state":"CA","stateName":"California","country":"United States","postalCode":"94111"},"tradeNames":[],"registration":{"secApproved":"1 April 1996","noticeFilings":null,"latestNoticeFiling":null},"staff":{"employees":355,"advisory":129,"brokerDealerReps":0,"insuranceAgents":0,"promoters":0},"aum":{"discretionary":52076899000,"discretionaryAccounts":67,"nonDiscretionary":0,"nonDiscretionaryAccounts":0,"wrapProgram":null,"nonUsClientsPct":63,"nonAumClients":1},"clientTypes":[{"label":"Pooled investment vehicles","clients":66,"regulatoryAum":52004485000},{"label":"Other","clients":null,"regulatoryAum":72414000}],"fees":[],"feeNotes":[],"custodians":[],"custodyNote":"Farallon Capital Management has custody of $49.30B for 67 clients.","otherCustodians":[],"leadership":[{"name":"Cameron Hillyer","title":"Chief Financial Officer & Managing Member (1/21)","crd":"6027922"},{"name":"Mark Wehrly","title":"Managing Member, Special Counsel & Chief Operating Officer (7/2014)","crd":"4344163"},{"name":"Kirstin Lynch","title":"Chief Compliance Officer","crd":"4872266"},{"name":"Richard Bollini II","title":"Managing Member","crd":"7351134"},{"name":"Colby Clark","title":"Managing Member","crd":"7351115"},{"name":"Joshua Dapice","title":"Managing Member","crd":"4357419"},{"name":"Philip Dreyfuss","title":"Managing Member","crd":"6767565"},{"name":"Hannah Dunn","title":"Managing Member & General Counsel","crd":"7682100"},{"name":"Varun Gehani","title":"Managing Member","crd":"5163324"},{"name":"Nicolas Giauque","title":"Managing Partner and Senior Managing Member (4/2025)","crd":"5069579"},{"name":"Avner Husen","title":"Managing Member","crd":"8208251"},{"name":"David Kim","title":"Managing Member","crd":"6296129"},{"name":"Michael Linn","title":"Managing Member","crd":"3129850"},{"name":"Cheng Luo","title":"Managing Member","crd":"8044693"},{"name":"David Posner","title":"Managing Member","crd":"2793341"},{"name":"Thomas Roberts","title":"Managing Member","crd":"5653061"},{"name":"Edric Saito","title":"Managing Member","crd":"4805137"},{"name":"Daniel Short","title":"Managing Member","crd":"5801269"},{"name":"Andrew Spokes","title":"Managing Member","crd":"1983183"},{"name":"Matthew Trentini","title":"Managing Member","crd":"7351718"},{"name":"John Warren","title":"Managing Member","crd":"3094530"}],"ownership":[{"label":"Farallon Capital Management, L.P.","detail":"Member in the 75% or more ownership band and a control person, since April 2018."},{"label":"Andrew Spokes","detail":"Indirect owner: a limited partner of Farallon Capital Management, L.P. in the 25% to 50% band and a control person, since April 2018. Also managing member of Farallon Capital Management (GP), L.L.C. and a control person, since April 2018.","parent":"Farallon Capital Management, L.P."},{"label":"Farallon Capital Management (GP), L.L.C.","detail":"Indirect owner: general partner of Farallon Capital Management, L.P. and a control person, since April 2018.","parent":"Farallon Capital Management, L.P."},{"label":"Mark Wehrly","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since April 2018.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Thomas Roberts","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since April 2018.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Michael Linn","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since April 2018.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"John Warren","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since April 2018.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"David Kim","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since April 2018.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"David Posner","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since April 2018.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Philip Dreyfuss","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since April 2018.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Colby Clark","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since January 2021.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Richard Bollini II","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since January 2021.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Matthew Trentini","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since January 2021.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Cameron Hillyer","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since January 2021.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Nicolas Giauque","detail":"Indirect owner: senior managing member (4/2025) of Farallon Capital Management (GP), L.L.C. and a control person, since August 2021.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Varun Gehani","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since January 2022.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Joshua Dapice","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since January 2023.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Edric Saito","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since January 2023.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Daniel Short","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since January 2023.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Hannah Dunn","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since January 2023.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Cheng Luo","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since January 2025.","parent":"Farallon Capital Management (GP), L.L.C."},{"label":"Avner Husen","detail":"Indirect owner: managing member of Farallon Capital Management (GP), L.L.C. and a control person, since January 2026.","parent":"Farallon Capital Management (GP), L.L.C."}],"branchOffices":null,"filedOffices":{"otherThanPrincipal":1,"privateResidences":0},"listedOfficeAddresses":2,"officesByState":[{"state":"California","offices":1,"addresses":[{"street":"One Maritime Plaza, Suite 2100","city":"San Francisco","headquarters":true}]},{"state":"New York","offices":1,"addresses":[{"street":"510 Madison Avenue","city":"New York"}]}],"advFacts":{"source":{"file":"ia100226.zip","asOf":"2 October 2026"},"telephone":"415-421-2132","stateRegisteredReps":0,"otherAdviserReps":0,"compensation":["A percentage of assets under management","Performance-based fees"],"activities":["Portfolio management for pooled investment vehicles (other than investment companies)","Portfolio management for businesses (other than small businesses) or institutional clients"],"financialPlanningClients":null,"assetMix":[{"label":"Cash and cash equivalents","percent":1},{"label":"Other","percent":99,"detail":"Generally Private Equity and Debt Investments."}],"privateFunds":50},"sources":{"adv1FilingDate":"23 September 2026","adv1Url":"https://reports.adviserinfo.sec.gov/reports/ADV/107322/PDF/107322.pdf","brochureDate":null,"brochureUrl":null,"iapdCompiledDate":null,"retrievedDate":"15 October 2026","retrievedOn":"2026-10-15","adv1Pages":{},"brochurePages":{}},"otherBusiness":[],"faq":[{"question":"How many clients does Farallon Capital Management have?","answer":"Farallon Capital Management has 66 clients and manages $52.1 billion for them, as of September 2026.","source":"Form ADV Part 1A, Items 5.D and 5.F, filed 23 September 2026","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"What services does Farallon Capital Management offer?","answer":"Farallon Capital Management provides portfolio management for pooled vehicles and portfolio management for institutions.","source":"Form ADV Part 1A, Item 5.G, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"How many financial advisors does Farallon Capital Management have?","answer":"Farallon Capital Management has 0 investment adviser representatives registered with state securities authorities, out of 355 employees, and 129 perform investment advisory functions. None are registered representatives of a broker-dealer or licensed insurance agents.","source":"Form ADV Part 1A, Items 5.A and 5.B, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"What does Farallon Capital Management invest in?","answer":"At the end of its last fiscal year, Farallon Capital Management’s separately managed accounts held 99% generally private equity and debt investments. and 1% cash and equivalents. It advises 50 private funds.","source":"Form ADV Part 1A, Items 5.K.(1) and 7.B, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"Who owns Farallon Capital Management?","answer":"Farallon Capital Management is owned through a holding company by Andrew Spokes. Its direct owner is Farallon Capital Management, L.P. (75% or more).","source":"Form ADV Part 1A, Schedules A and B, filed 23 September 2026","sourceRef":{"doc":"adv1","section":"scheduleA"}},{"question":"How does Farallon Capital Management get paid?","answer":"Farallon Capital Management is paid through a percentage of assets under management and performance-based fees. Its Form ADV lists no commissions among how it is paid.","source":"Form ADV Part 1A, Item 5.E, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}}],"holdings":{"url":"https://nivawealth.com/firms/farallon-capital-management-107322/holdings","form":"13F-HR","periodOfReport":"2026-06-30","filedOn":"2026-08-14","filingIndexUrl":"https://www.sec.gov/Archives/edgar/data/909661/000090883426000432/0000908834-26-000432-index.html","totalValue":21675731270,"positionCount":89,"top10Share":0.6214098487021886,"top10":[{"issuer":"STATE STR SPDR S&P 500 ETF T","titleOfClass":"TR UNIT","cusip":"78462F103","value":4480620000,"shares":6000000,"shareType":"SH","putCall":"Put"},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"COM","cusip":"76155X100","value":2537793075,"shares":13550796,"shareType":"SH","priorValue":1323066411,"priorShares":13604796},{"issuer":"ELECTRONIC ARTS INC","titleOfClass":"COM","cusip":"285512109","value":1623814280,"shares":7919500,"shareType":"SH","priorValue":1522908900,"priorShares":7470000},{"issuer":"BRIDGEBIO PHARMA INC","titleOfClass":"COM","cusip":"10806X102","value":800143332,"shares":10743063,"shareType":"SH","priorValue":695479282,"priorShares":9365463},{"issuer":"PROTAGONIST THERAPEUTICS INC","titleOfClass":"COM","cusip":"74366E102","value":778248897,"shares":6348906,"shareType":"SH","priorValue":669174692,"priorShares":6348906},{"issuer":"EXELIXIS INC","titleOfClass":"COM","cusip":"30161Q104","value":732794424,"shares":13468010,"shareType":"SH","priorValue":562331219,"priorShares":13111010},{"issuer":"LIQUIDIA CORPORATION","titleOfClass":"COM NEW","cusip":"53635D202","value":666944480,"shares":8365038,"shareType":"SH","priorValue":326678874,"priorShares":8656038},{"issuer":"AMAZON COM INC","titleOfClass":"COM","cusip":"023135106","value":627547790,"shares":2632994,"shareType":"SH","priorValue":878564918,"priorShares":4218394},{"issuer":"LANTHEUS HLDGS INC","titleOfClass":"COM","cusip":"516544103","value":619431160,"shares":5583479,"shareType":"SH","priorValue":423506882,"priorShares":5583479},{"issuer":"NATERA INC","titleOfClass":"COM","cusip":"632307104","value":602175451,"shares":2218366,"shareType":"SH","priorValue":641441126,"priorShares":3207366}],"positionsListed":89,"positions":[{"issuer":"STATE STR SPDR S&P 500 ETF T","titleOfClass":"TR UNIT","cusip":"78462F103","value":4480620000,"shares":6000000,"shareType":"SH","putCall":"Put"},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"COM","cusip":"76155X100","value":2537793075,"shares":13550796,"shareType":"SH","priorValue":1323066411,"priorShares":13604796},{"issuer":"ELECTRONIC ARTS INC","titleOfClass":"COM","cusip":"285512109","value":1623814280,"shares":7919500,"shareType":"SH","priorValue":1522908900,"priorShares":7470000},{"issuer":"BRIDGEBIO PHARMA INC","titleOfClass":"COM","cusip":"10806X102","value":800143332,"shares":10743063,"shareType":"SH","priorValue":695479282,"priorShares":9365463},{"issuer":"PROTAGONIST THERAPEUTICS INC","titleOfClass":"COM","cusip":"74366E102","value":778248897,"shares":6348906,"shareType":"SH","priorValue":669174692,"priorShares":6348906},{"issuer":"EXELIXIS INC","titleOfClass":"COM","cusip":"30161Q104","value":732794424,"shares":13468010,"shareType":"SH","priorValue":562331219,"priorShares":13111010},{"issuer":"LIQUIDIA CORPORATION","titleOfClass":"COM NEW","cusip":"53635D202","value":666944480,"shares":8365038,"shareType":"SH","priorValue":326678874,"priorShares":8656038},{"issuer":"AMAZON COM INC","titleOfClass":"COM","cusip":"023135106","value":627547790,"shares":2632994,"shareType":"SH","priorValue":878564918,"priorShares":4218394},{"issuer":"LANTHEUS HLDGS INC","titleOfClass":"COM","cusip":"516544103","value":619431160,"shares":5583479,"shareType":"SH","priorValue":423506882,"priorShares":5583479},{"issuer":"NATERA INC","titleOfClass":"COM","cusip":"632307104","value":602175451,"shares":2218366,"shareType":"SH","priorValue":641441126,"priorShares":3207366},{"issuer":"UNITEDHEALTH GROUP INC","titleOfClass":"COM","cusip":"91324P102","value":528071215,"shares":1270532,"shareType":"SH","priorValue":492935427,"priorShares":1821706},{"issuer":"THERMO FISHER SCIENTIFIC INC","titleOfClass":"COM","cusip":"883556102","value":526019392,"shares":1049185,"shareType":"SH","priorValue":433276322,"priorShares":881485},{"issuer":"ROIVANT SCIENCES LTD","titleOfClass":"SHS","cusip":"G76279101","value":506395510,"shares":14309000,"shareType":"SH","priorValue":267997500,"priorShares":9675000},{"issuer":"AON PLC","titleOfClass":"SHS CL A","cusip":"G0403H108","value":458581990,"shares":1382562,"shareType":"SH","priorValue":811029294,"priorShares":2512638},{"issuer":"BOSTON SCIENTIFIC CORP","titleOfClass":"COM","cusip":"101137107","value":449044133,"shares":10521184,"shareType":"SH","priorValue":468785421,"priorShares":7470684},{"issuer":"BROADCOM INC","titleOfClass":"COM","cusip":"11135F101","value":435092450,"shares":1151800,"shareType":"SH","priorValue":550773045,"priorShares":1779500},{"issuer":"MICROSOFT CORP","titleOfClass":"COM","cusip":"594918104","value":415120156,"shares":1112863,"shareType":"SH","priorValue":867966842,"priorShares":2344779},{"issuer":"TANGO THERAPEUTICS INC","titleOfClass":"COM","cusip":"87583X109","value":383779020,"shares":12277000,"shareType":"SH","priorValue":190317838,"priorShares":9097411},{"issuer":"KKR & CO INC","titleOfClass":"COM","cusip":"48251W104","value":377977574,"shares":4118300,"shareType":"SH","priorValue":432141500,"priorShares":4671800},{"issuer":"SYNOPSYS INC","titleOfClass":"COM","cusip":"871607107","value":370059672,"shares":829600,"shareType":"SH","priorValue":481049184,"priorShares":1213300},{"issuer":"BEAM THERAPEUTICS INC","titleOfClass":"COM","cusip":"07373V105","value":351313111,"shares":10236396,"shareType":"SH","priorValue":241509806,"priorShares":10134696},{"issuer":"CRINETICS PHARMACEUTICALS IN","titleOfClass":"COM","cusip":"22663K107","value":336372047,"shares":8989098,"shareType":"SH","priorValue":302839719,"priorShares":8338098},{"issuer":"GRAIL INC","titleOfClass":"COM","cusip":"384747101","value":284111340,"shares":4161584,"shareType":"SH","priorValue":168150389,"priorShares":3253684},{"issuer":"WABTEC","titleOfClass":"COM","cusip":"929740108","value":241158009,"shares":894503,"shareType":"SH","priorValue":402205904,"priorShares":1609403},{"issuer":"IMMUNOVANT INC","titleOfClass":"COM","cusip":"45258J102","value":223666650,"shares":5805000,"shareType":"SH","priorValue":38402640,"priorShares":1546000},{"issuer":"TWIST BIOSCIENCE CORP","titleOfClass":"COM","cusip":"90184D100","value":219792832,"shares":2136400,"shareType":"SH","priorValue":67841928,"priorShares":1427650},{"issuer":"AGIOS PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"00847X104","value":219594714,"shares":5917400,"shareType":"SH","priorValue":192289720,"priorShares":5684000},{"issuer":"ARAMARK","titleOfClass":"COM","cusip":"03852U106","value":206304094,"shares":3625731,"shareType":"SH","priorValue":248730373,"priorShares":6135431},{"issuer":"BAIDU INC","titleOfClass":"SPON ADR REP A","cusip":"056752108","value":137580588,"shares":1203785,"shareType":"SH","priorValue":49446525,"priorShares":443785},{"issuer":"NOVO-NORDISK A S","titleOfClass":"ADR","cusip":"670100205","value":125554860,"shares":2619000,"shareType":"SH","priorValue":28738500,"priorShares":782000},{"issuer":"ACADIA HEALTHCARE COMPANY IN","titleOfClass":"COM","cusip":"00404A109","value":124640224,"shares":4220800,"shareType":"SH","priorValue":40623752,"priorShares":1736800},{"issuer":"BRIGHTSPRING HEALTH SVCS INC","titleOfClass":"COM","cusip":"10950A106","value":120845472,"shares":1732800,"shareType":"SH","priorValue":68900370,"priorShares":1617000},{"issuer":"ASTRAZENECA PLC","titleOfClass":"ORD","cusip":"G0593M107","value":108841880,"shares":574000,"shareType":"SH","priorValue":44670133,"priorShares":226499},{"issuer":"JOHNSON & JOHNSON","titleOfClass":"COM","cusip":"478160104","value":103619760,"shares":408000,"shareType":"SH","priorValue":36177120,"priorShares":148000},{"issuer":"ISHARES TR","titleOfClass":"ISHARES SEMICDTR","cusip":"464287523","value":83298800,"shares":130000,"shareType":"SH","putCall":"Put"},{"issuer":"STRATEGY INC","titleOfClass":"NOTE 12/0","cusip":"594972AS0","value":75366666,"shares":87858000,"shareType":"PRN","priorValue":32877339,"priorShares":39500000},{"issuer":"PARABILIS MEDICINES INC","titleOfClass":"COM","cusip":"698955101","value":64817634,"shares":2368200,"shareType":"SH"},{"issuer":"NOVARTIS AG","titleOfClass":"SPONSORED ADR","cusip":"66987V109","value":56889360,"shares":363000,"shareType":"SH"},{"issuer":"GUARDANT HEALTH INC","titleOfClass":"COM","cusip":"40131M109","value":48339666,"shares":322200,"shareType":"SH","priorValue":738960,"priorShares":8000},{"issuer":"VNET GROUP INC","titleOfClass":"NOTE 2.000%10/0","cusip":"90138AAE3","value":46808834,"shares":45000000,"shareType":"PRN","priorValue":44515553,"priorShares":45000000},{"issuer":"AVALO THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"05338F306","value":46163040,"shares":2498000,"shareType":"SH","priorValue":13675880,"priorShares":916000},{"issuer":"JOYY INC","titleOfClass":"ADS REPSTG COM A","cusip":"46591M109","value":46140208,"shares":699200,"shareType":"SH","priorValue":33761098,"priorShares":578200},{"issuer":"ASSEMBLY BIOSCIENCES INC","titleOfClass":"COM NEW","cusip":"045396207","value":44094133,"shares":1604590,"shareType":"SH","priorValue":34065623,"priorShares":1227590},{"issuer":"ENANTA PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"29251M106","value":35257385,"shares":2418202,"shareType":"SH","priorValue":36271617,"priorShares":2871862},{"issuer":"MAZE THERAPEUTICS INC","titleOfClass":"COM","cusip":"578784100","value":33057170,"shares":1107814,"shareType":"SH","priorValue":11134050,"priorShares":373000},{"issuer":"CG ONCOLOGY INC","titleOfClass":"COM","cusip":"156944100","value":28420000,"shares":400000,"shareType":"SH","putCall":"Call"},{"issuer":"MERCK & CO INC","titleOfClass":"COM","cusip":"58933Y105","value":25571500,"shares":199000,"shareType":"SH","priorValue":43424690,"priorShares":361000},{"issuer":"WARBY PARKER INC","titleOfClass":"CL A COM","cusip":"93403J106","value":25121520,"shares":828000,"shareType":"SH"},{"issuer":"PERCEPTIVE CAP SOLUTIONS COR","titleOfClass":"CL A ORD SHS","cusip":"G70077105","value":24480000,"shares":2250000,"shareType":"SH","priorValue":24682500,"priorShares":2250000},{"issuer":"KAILERA THERAPEUTICS INC","titleOfClass":"COMMON STOCK","cusip":"482931102","value":24233000,"shares":1100000,"shareType":"SH"},{"issuer":"RIO TINTO PLC","titleOfClass":"SPONSORED ADR","cusip":"767204100","value":17417282,"shares":183475,"shareType":"SH","priorValue":5019002,"priorShares":53800},{"issuer":"AXALTA COATING SYS LTD","titleOfClass":"COM","cusip":"G0750C108","value":16357160,"shares":478000,"shareType":"SH"},{"issuer":"ABIVAX SA","titleOfClass":"SPONSORED ADS","cusip":"00370M103","value":16257720,"shares":122000,"shareType":"SH","priorValue":222700,"priorShares":2000},{"issuer":"VNET GROUP INC","titleOfClass":"SPONSORED ADS A","cusip":"90138A103","value":16015680,"shares":1992000,"shareType":"SH","priorValue":5229881,"priorShares":623347},{"issuer":"NETEASE COM INC","titleOfClass":"SPONSORED ADS","cusip":"64110W102","value":15825290,"shares":123500,"shareType":"SH","priorValue":32599055,"priorShares":291219},{"issuer":"BIOGEN INC","titleOfClass":"COM","cusip":"09062X103","value":15340260,"shares":71000,"shareType":"SH"},{"issuer":"TAYSHA GENE THERAPIES INC","titleOfClass":"COM SHS","cusip":"877619106","value":15322500,"shares":2250000,"shareType":"SH"},{"issuer":"MOBIA MED INC","titleOfClass":"COMMON STOCK","cusip":"60705V103","value":15122664,"shares":1128557,"shareType":"SH"},{"issuer":"STRATEGY INC","titleOfClass":"NOTE 2.250% 6/1","cusip":"594972AN1","value":14189967,"shares":15000000,"shareType":"PRN"},{"issuer":"MINERVA NEUROSCIENCES INC","titleOfClass":"COM NEW","cusip":"603380205","value":13125750,"shares":2365000,"shareType":"SH","priorValue":14249125,"priorShares":2365000},{"issuer":"ALAMAR BIOSCIENCES INC","titleOfClass":"COMMON STOCK","cusip":"010911105","value":12539961,"shares":462900,"shareType":"SH"},{"issuer":"ALVOTECH","titleOfClass":"ORDINARY SHARES","cusip":"L01800108","value":10552201,"shares":2859675,"shareType":"SH","priorValue":684885,"priorShares":199675},{"issuer":"BETA BIONICS INC","titleOfClass":"COM","cusip":"08659B102","value":9323650,"shares":595000,"shareType":"SH","priorValue":36151358,"priorShares":3607920},{"issuer":"INFLARX NV","titleOfClass":"COM","cusip":"N44821101","value":7448000,"shares":3325000,"shareType":"SH"},{"issuer":"SCOTTS MIRACLE-GRO CO","titleOfClass":"CL A","cusip":"810186106","value":5993680,"shares":88000,"shareType":"SH"},{"issuer":"WAYSTAR HLDG CORP","titleOfClass":"COM","cusip":"946784105","value":5438397,"shares":264900,"shareType":"SH"},{"issuer":"BRUNSWICK CORP","titleOfClass":"COM","cusip":"117043109","value":5138640,"shares":61000,"shareType":"SH"},{"issuer":"GENTEX CORP","titleOfClass":"COM","cusip":"371901109","value":5028730,"shares":199000,"shareType":"SH"},{"issuer":"IDEXX LABS INC","titleOfClass":"COM","cusip":"45168D104","value":4737960,"shares":9000,"shareType":"SH"},{"issuer":"PRIME MEDICINE INC","titleOfClass":"COM","cusip":"74168J101","value":4578711,"shares":1240843,"shareType":"SH","priorValue":4318134,"priorShares":1240843},{"issuer":"COMMERCIAL METALS CO","titleOfClass":"COM","cusip":"201723103","value":4204250,"shares":67000,"shareType":"SH"},{"issuer":"JATT II ACQUISITION CORP","titleOfClass":"ORD SHS","cusip":"G50765109","value":3408000,"shares":300000,"shareType":"SH"},{"issuer":"SAGIMET BIOSCIENCES INC","titleOfClass":"COM SER A","cusip":"786700104","value":3207950,"shares":415000,"shareType":"SH"},{"issuer":"STRATEGY INC","titleOfClass":"NOTE 3/0","cusip":"594972AU5","value":2318158,"shares":2632000,"shareType":"PRN"},{"issuer":"SUMMIT MIDSTREAM CORPORATION","titleOfClass":"COM","cusip":"86614G101","value":1657935,"shares":58214,"shareType":"SH","priorValue":1760391,"priorShares":58214},{"issuer":"TEVA PHARMACEUTICAL INDS LTD","titleOfClass":"SPONSORED ADS","cusip":"881624209","value":1355200,"shares":40000,"shareType":"SH","priorValue":10662480,"priorShares":354000},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"*W EXP 12/17/202","cusip":"76155X118","value":1128799,"shares":120085,"shareType":"SH","priorValue":208948,"priorShares":120085},{"issuer":"COGENT BIOSCIENCES INC","titleOfClass":"COM","cusip":"19240Q201","value":657900,"shares":17000,"shareType":"SH","priorValue":654330,"priorShares":17000},{"issuer":"ALEANNA INC","titleOfClass":"*W EXP 12/13/202","cusip":"01444V111","value":297000,"shares":990000,"shareType":"SH","priorValue":801900,"priorShares":990000},{"issuer":"ALEANNA INC","titleOfClass":"COM CL A","cusip":"01444V103","value":227360,"shares":78400,"shareType":"SH","priorValue":649936,"priorShares":78400},{"issuer":"WELLTOWER INC","titleOfClass":"COM","cusip":"95040Q104","value":226970,"shares":1000,"shareType":"SH","priorValue":39542000,"priorShares":200000},{"issuer":"SOLID POWER INC","titleOfClass":"*W EXP 12/08/202","cusip":"83422N113","value":41423,"shares":405316,"shareType":"SH","priorValue":88359,"priorShares":405316},{"issuer":"BLUE GOLD LTD","titleOfClass":"*W EXP 04/01/203","cusip":"G1331C112","value":30696,"shares":255800,"shareType":"SH","priorValue":60000,"priorShares":300000},{"issuer":"PACIFIC BIOSCIENCES CALIF IN","titleOfClass":"COM","cusip":"69404D108","value":23856,"shares":14200,"shareType":"SH","priorValue":178200,"priorShares":135000},{"issuer":"GERON CORP","titleOfClass":"COM","cusip":"374163103","value":18432,"shares":14400,"shareType":"SH","priorValue":64070,"priorShares":43000},{"issuer":"NVNI GROUP LIMITED","titleOfClass":"*W EXP 11/01/202","cusip":"G50716110","value":17550,"shares":375000,"shareType":"SH","priorValue":17813,"priorShares":375000},{"issuer":"CANOPY GROWTH CORPORATION","titleOfClass":"COM NEW","cusip":"138035704","value":17100,"shares":18000,"shareType":"SH","priorValue":28476,"priorShares":30000},{"issuer":"RANI THERAPEUTICS HLDGS INC","titleOfClass":"COM CL A","cusip":"753018100","value":15740,"shares":20700,"shareType":"SH","priorValue":57314,"priorShares":78000},{"issuer":"BEYOND MEAT INC","titleOfClass":"COM","cusip":"08862E109","value":14250,"shares":19000,"shareType":"SH","priorValue":13330,"priorShares":19000}]},"notice":"Compiled from public SEC Form ADV filings on the dates in `sources`. Facts as filed; not a rating, ranking, or recommendation. Niva Wealth is not affiliated with this firm. Disciplinary history is deliberately not included here or on the page; the SEC publishes the complete record at the `iapdUrl` above."}